Back to Stakeholders

Centre for Addiction and Mental Health

Also known as: CAMH

13 Trials

The Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health teaching hospital, located in Toronto, Ontario. CAMH is a major hub for psychedelic research in Canada, running trials on psilocybin, MDMA, and ketamine across a range of psychiatric indications.

Quick Facts

Type
hospital
Website
Visit

Sponsored Trials

9
Not yet recruitingII

Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder

Start Date
Compounds
Psilocybin, Placebo
RecruitingI

Psilocybin for Treatment-Resistant Depression in Autism With Pre-Post Brain and Cognitive Measurement to Understand Mechanisms (PAT-DA)

Start Date
Compounds
Psilocybin
RecruitingII

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND) (TRANSCEND)

Start Date
Compounds
Psilocybin
RecruitingII

Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST) (SYNVEST)

Start Date
Compounds
Psilocybin, Placebo
RecruitingI

Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD (PAP-OCD)

Start Date
Compounds
Psilocybin
Active not recruitingII

Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment

Start Date
Compounds
Psilocybin, Placebo
RecruitingII

Does Psilocybin Require Psychedelic Effects to Treat Depression? (PSI-RIS)

Start Date
Compounds
Psilocybin, Placebo
CompletedNA

Neural Correlates of Ketamine’s Anti-suicidal Effects in Bipolar Depression (DEEPP)

Start Date
Compounds
Ketamine
CompletedNA

Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders) (SURE-ECT)

Start Date
Compounds
Ketamine

Collaborated Trials

4
RecruitingI

Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression (Psilo-BD)

Start Date
Compounds
Psilocybin
RecruitingII

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin (PSI-1V2)

Start Date
Compounds
Psilocybin
Enrolling by invitationIV

Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)

Start Date
Compounds
Ketamine, Placebo
Unknown statusNA

Auditory MMN EEG in TRD in Response to Ketamine

Start Date
Compounds
Ketamine